Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EPS (Basic): 2020-2025

Historic EPS (Basic) for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$0.62.

  • Biofrontera's EPS (Basic) rose 36.73% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 332.81%. This contributed to the annual value of -$3.22 for FY2024, which is 75.27% up from last year.
  • As of Q3 2025, Biofrontera's EPS (Basic) stood at -$0.62, which was down 8.77% from -$0.57 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's EPS (Basic) registered a high of $4.55 during Q4 2023, and its lowest value of -$7.23 during Q2 2023.
  • For the 3-year period, Biofrontera's EPS (Basic) averaged around -$1.18, with its median value being -$0.57 (2025).
  • Per our database at Business Quant, Biofrontera's EPS (Basic) spiked by 262.50% in 2023 and then tumbled by 1,040.00% in 2025.
  • Biofrontera's EPS (Basic) (Quarterly) stood at -$1.38 in 2021, then crashed by 102.90% to -$2.80 in 2022, then skyrocketed by 262.50% to $4.55 in 2023, then crashed by 96.26% to $0.17 in 2024, then skyrocketed by 36.73% to -$0.62 in 2025.
  • Its last three reported values are -$0.62 in Q3 2025, -$0.57 for Q2 2025, and -$0.47 during Q1 2025.